[Resistance to antiretroviral drugs: a clinical, public health and health policy debate].
Guerra Romero
L
L
Secretaría del Plan Nacional sobre el Sida. Ministerio de Sanidad y Consumo. Madrid.
Parras Vázquez
F
F
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000517:prevention & control; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial / Q000235:genetics*; D005260:Female; D005838:Genotype; D006678:HIV / Q000187:drug effects* / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006291:Health Policy; D006801:Humans; D008297:Male; D011247:Pregnancy; D011634:Public Health; D012106:Research; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D013030:Spain; D019562:Viral Load; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine